Matching slides 110,355
Current window 64,981-65,010
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all

Component

64,981-65,010 of 110,355

filter-aware
34
Includes non-GAAP measures and constant currency comparisons.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations 1 hit
35
Standard financial reconciliation table for non-GAAP measures.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations 1 hit
36
The table reconciles GAAP net loss to adjusted net income attributable to Bausch Health Companies Inc.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations 1 hit
39
Includes a secondary table for noncontrolling interest adjustments.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations 1 hit
43
The table reconciles GAAP operating cash flow to non-GAAP adjusted cash flow by adding back specific items like legal settlements, separation/IPO costs, and Amoun operating activities.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations 1 hit
44
The table provides a detailed breakdown of adjustments including impairments, restructuring, and other non-recurring items.Bausch Health Companies | Results Presentation Deck | 50 slides · Bausch Health
Conference presentation Investor relations 1 hit
08
The slide uses a process flow diagram to contrast a traditional industrial process with a proprietary one.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
09
The slide uses a dramatic image of a field under a stormy sky to visually represent the 'bottleneck' or 'disruption' theme.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
10
Includes a comparison table against commodity soy oil and sustainability metrics vs. canola.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · Satisfaction1 hit
11
Includes sustainability claims and industry certifications.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · Action1 hit
13
The slide uses a circular value chain diagram on the right and a list of ESG outcomes on the left.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · Action1 hit
16
The slide uses a split-layout with a financial table on the left and qualitative commentary on the right.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · Action1 hit
19
The slide uses a numbered list paired with a comparison table to illustrate competitive moats.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · Action1 hit
21
The table provides a bridge between reported figures and adjusted figures excluding mark-to-market timing differences.Benson Hill | Results Presentation Deck | 27 slides · Benson Hill
Conference presentation Investor relations Beat · Action1 hit
05
The slide uses a comparative visual framework to contrast healthy cells (no binding) with cancer cells (CAB binding).BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
09
Uses a comparative framework to highlight unmet medical needs in two specific cancer indications.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market Sizing1 hit
11
The slide uses a process-flow diagram to map patient cohorts to clinical outcomes and subsequent study advancement decisions.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
14
Clinical trial data showing PFS at 3 months for Liposarcoma and Synovial Sarcoma cohorts.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
15
Includes specific clinical trial terminology (CTCAE, SAE, RP2D, Q2W).BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
16
The slide uses a grid of metrics to establish the total addressable market and clinical benchmarks.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
22
The slide uses a grid of metrics to define the total addressable market and the specific target segment.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
23
The chart is a waterfall plot showing percentage change in tumor size for individual patients.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
24
The slide uses a 2x2 grid of metrics to frame the market problem, followed by specific target population and success threshold data.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
25
The chart displays longitudinal data for two specific patients, showing sustained complete response.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
26
SCCHN = Squamous Cell Carcinoma of the Head and Neck. ROR2 is the target biomarker.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
30
The slide uses a combination of a comparison table for clinical data and a dot plot for NHP toxicity data.BioAtla | Investor Presentation Deck | 37 slides · BioAtla
Pitch deck Investor relations 1 hit
08
The slide uses a structured grid layout to categorize key performance indicators.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Loop · Golden Circle1 hit
09
The slide uses a list-based timeline/milestone format to highlight growth across five key areas.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Loop · Golden Circle1 hit
10
The slide highlights organizational scale and diversity metrics as of Dec 31, 2021.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Loop · Golden Circle1 hit
11
The slide uses a structured layout to present four pillars of corporate social responsibility.BioNTech | Investor Presentation Deck | 28 slides · BioNTech
Pitch deck Investor relations Loop · Golden Circle1 hit